The effectiveness of Orem's self-care program on headache-related disability in migraine patients

被引:0
|
作者
Mahmoudzadeh-Zarandi, Fatemeh [1 ]
Hamedanizadeh, Farahrooz [2 ]
Ebadi, Abbas [3 ]
Raiesifar, Afsaneh [4 ]
机构
[1] Birjand Univ Med Sci, Sch Paramed, Dept Operat Room, Birjand, Iran
[2] Baqiyatallah Univ Med Sci, Sch Nursing, Dept Med Surg Nursing, Tehran, Iran
[3] Baqiyatallah Univ Med Sci, Sch Nursing, Dept Nursing, Behav Sci Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Nursing & Midwifery, Dept Med Surg Nursing, Tehran, Iran
关键词
Migraine Headache; Orem Self-care Model; MIDAS; Nursing; Iran;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Providing a self-care program appropriate for patient needs in a supportive educative nursing system format could reduce migraine-induced disability. This study was designed to determine the effectiveness of Orem's self-care program on headache related disability in migraine patients. Methods: In this randomized clinical trial, episodic migraine patients with or without aura who signed the informed consent were randomly assigned to two groups (44 patients each). The data collection tools included a demographic questionnaire, the Migraine Disability Assessment (MIDAS) questionnaire, an Orem cognition form, and a self-care checklist. The programs were held as four 30 to 45 minutes training sessions for experimental group. The MIDAS were filled out before and three months after program in two groups. Data were analyzed with SPSS statistical software, version 16 and using chi-square, Mann-Whitney and Wilcoxon tests. Results: There was no statistically significant difference between the two groups in terms of demographic variables (P > 0.05). The mean total MIDAS score in the experimental group, before and after the intervention was 28.1 +/- 17.5 and 6.03 +/- 4.52, respectively (P = 0.001); and for the control group, it was 37.6 +/- 16.4 and 55.6 +/- 14.5, respectively (P < 0.001). Also, there was a statistically significant difference in disability indices between the two groups after the intervention (P < 0.001). Conclusion: Self-care program was suitable for needs assessment and provided basis for acquiring positive results in order to decrease disability and saved patient treatment costs.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [1] Headache-related disability in the management of migraine
    Lipton, RB
    Stewart, WF
    Goadsby, PJ
    [J]. NEUROLOGY, 2001, 56 (06) : S1 - S3
  • [2] Anxiety and Depression in Migraine Patients and Their Relation with Headache-Related Disability
    Zandifar, A.
    Haghdoost, F.
    Zandifar, S.
    Manouchehri, N.
    Saadatnia, M.
    [J]. HEADACHE, 2014, 54 : 43 - 44
  • [3] The Impact of Fremanezumab on Headache-Related Disability in Patients with Episodic Migraine using the Migraine Disability Assessment
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. NEUROLOGY, 2018, 90
  • [4] The Impact of Fremanezumab on Headache-related Disability in Patients with Episodic Migraine Using the Migraine Disability Assessment
    Winner, P. K.
    Fitzgerald, T.
    Gandhi, S. K.
    Yeung, P. P.
    Cohen, J. M.
    Ma, Y.
    Aycardi, E.
    [J]. HEADACHE, 2018, 58 : 126 - 126
  • [5] The Impact of Fremanezumab on Headache-related Disability in Patients With Episodic Migraine Using the Migraine Disability Assessment
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [6] Psychological factors associated with headache frequency, intensity, and headache-related disability in migraine patients
    Klonowski, Theresa
    Kropp, Peter
    Straube, Andreas
    Ruscheweyh, Ruth
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (02) : 1255 - 1266
  • [7] Psychological factors associated with headache frequency, intensity, and headache-related disability in migraine patients
    Theresa Klonowski
    Peter Kropp
    Andreas Straube
    Ruth Ruscheweyh
    [J]. Neurological Sciences, 2022, 43 : 1255 - 1266
  • [8] The impact of fremanezumab on headache-related disability in patients with chronic migraine using the Headache Impact Test
    Winner, Paul K.
    Fitzgerald, Timothy
    Gandhi, Sanjay K.
    Yeung, Paul P.
    Cohen, Joshua M.
    Ma, Yuju
    Aycardi, Ernesto
    [J]. JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [9] The role of headache-related disability in migraine management - Implications for headache treatment guidelines
    Lipton, RB
    Silberstein, SD
    [J]. NEUROLOGY, 2001, 56 (06) : S35 - S42
  • [10] Perceived self-efficacy and headache-related disability
    French, DJ
    Holroyd, KA
    Pinell, C
    Malinoski, PT
    O'Donnell, F
    Hill, KR
    [J]. HEADACHE, 2000, 40 (08): : 647 - 656